| Kevin V Knutson, LCMHC, NCC | |
|
1018 E Oakhill Dr, Alpine, UT 84004-1733 | |
| (877) 415-4060 | |
| Not Available |
| Full Name | Kevin V Knutson |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 1018 E Oakhill Dr, Alpine, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326254731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 310195-6004 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin V Knutson, LCMHC, NCC Po Box 247, Loa, UT 84747-0247 Ph: (435) 201-7317 | Kevin V Knutson, LCMHC, NCC 1018 E Oakhill Dr, Alpine, UT 84004-1733 Ph: (877) 415-4060 |
News Archive
Young adult men who watched more violence on television showed indications of less mature brain development and poorer executive functioning, according to the results of an Indiana University School of Medicine study published online in the journal Brain and Cognition.
The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide. Past research has suggested that ecstasy users perform worse than nonusers on some tests of mental ability. But there are concerns that the methods used to conduct that research were flawed, and the experiments overstated the cognitive differences between ecstasy users and nonusers.
Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.
Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after returning home.
The US Food and Drug Administration is holding a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, that manufactures breast cancer drug Avastin. A handful of breast cancer patients testified Tuesday that Avastin helped in treating their metastatic breast cancer but a review of studies conducted by the FDA's Center for Drug Evaluation and Research suggests the risks outweigh the benefits of Avastin for treating breast cancer, FDA officials said at the hearing.
› Verified 1 days ago
Tamara Chapman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 97 N 300 E, Alpine, UT 84004 Phone: 801-227-4957 | |
Caidy Atwood, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 20 W Main Street Ct Ste 200, Alpine, UT 84004 Phone: 385-387-1099 Fax: 385-387-1243 | |
Jennifer Ashley Sorensen, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 256 N Main St Ste C, Alpine, UT 84004 Phone: 385-265-2577 | |
Matthew C Wright, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 45 W Main Street Ct Ste 255, Alpine, UT 84004 Phone: 385-446-5116 |